← Leaderboards
Brian Weinrick
Trudeau Institute, Inc.
$742,500
Attributed
$742,500
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $297K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$742,500 · 2
By mechanism
R21$544,500 · 1
R03$198,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Tuberculosis”
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Yunda Huang · Fred Hutchinson Cancer Center$52,438,893
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$31,845,607
- Jay Evans · University Of Montana$15,453,274
Research focus
TuberculosisHistologicMycobacterium TuberculosisDrug ToleranceNecrosisIsoniazidInnovationMouse ModelReporterTuberculosis DrugsResearch Clinical TestingPathologyCellsLungGranulomaCell SurfaceAnti-Bacterial AgentsBiologyAttenuatedAnimal TestingAdoptedDrug EfficacyDeoxyribonucleasesAnimal Model
Grant awards (4)
Development of a mouse model of tuberculosis that generates human-like pathology$247,500
R21 · FY2023 · AI · contact PI
Development of a mouse model of tuberculosis that generates human-like pathology$297,000
R21 · FY2022 · AI · contact PI
Inhaled DNase as an Adjunctive Tuberculosis Therapy$99,000
R03 · FY2020 · AI · contact PI
Inhaled DNase as an Adjunctive Tuberculosis Therapy$99,000
R03 · FY2019 · AI · contact PI